Back to search

Expression Analyses of Epidermal Growth Factor Receptor and HER-2/neu: No Advantage of Prediction of Recurrence or Survival in Breast Cancer Patients

Data up to Jan 2025

Published1996
Citations28
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Expression Analyses of Epidermal Growth Factor Receptor and HER-2/neu: No Advantage of… (1996) – Oncology | Metascience Observatory Explorer